Tackling the blind spot of poor-quality medicines in Universal Health Coverage

Journal of Pharmaceutical Policy and Practice
E S F OrubuV J Wirtz

Abstract

Universal Health Coverage (UHC) is challenged by the prevalence of poor-quality medicines, those that either do not meet required specifications (substandard) or are outrightly fraudulent (falsified), especially in Low- and Middle-Income Countries, LMICs. Whereas poor-quality medicines are a significant burden in these countries, medicine quality still remains a neglected component of UHC programs. This article describes key barriers to quality medicines and presents five select approaches leveraging the scale-up of UHC for medicine quality assurance. Barriers to medicine quality assurance, while numerous, are described in five key inter-related domains as: low political priority, weak regulatory systems capacity, poor access to accredited facilities and licensed outlets, medicine manufacturing and other supply-chain challenges, and lack of public awareness. Five select approaches for leveraging the scale-up of UHC for medicine quality assurance in LMICs are (1): political commitment (2) strengthening the capacity of regulatory authorities and investment in detection technologies as part of national security (3); licensing of medicines outlets and expanding pharmacovigilance (4); strengthening the supply-chain; and (5) public a...Continue Reading

References

Jul 13, 2012·Nature·David H Peters, Gerald Bloom
Sep 18, 2012·Bulletin of the World Health Organization·Ernst SpaanRob Baltussen
Jul 12, 2013·PLoS Medicine·Agnes BinagwahoAmir Attaran
Nov 14, 2013·Pharmacy Practice·Chukwuemeka M UbakaMaxwell O Adibe
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Tim K MackeyThomas Kubic
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Gaurvika M L NayyarJoel G Breman
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·John P RenschlerRamanan Laxminarayan
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Amir Attaran
Sep 29, 2015·Journal of Pharmaceutical Policy and Practice·Edmund RuttaHiiti Sillo
Mar 10, 2016·BMJ : British Medical Journal·Andrew Jack
Apr 2, 2016·Bulletin of the World Health Organization·Jenny LiuChinwoke Isiguzo
Apr 6, 2016·BMJ Open·Edwin MedinaJosep María Suñé
Nov 12, 2016·Lancet·Veronika J WirtzMichael R Reich
Feb 7, 2018·Bulletin of the World Health Organization·Jude NwokikePhillip P Nguyen
Jul 28, 2018·Journal of Research in Pharmacy Practice·Mwasi Mary Ann MukokinyaBrian Godman
Sep 21, 2018·BMJ Global Health·Serena VickersCéline Caillet
Nov 7, 2018·Antimicrobial Agents and Chemotherapy·Zohar B Weinstein, Muhammad H Zaman
Jan 25, 2019·The American Journal of Tropical Medicine and Hygiene·Sachiko OzawaDaniel R Evans
Dec 14, 2019·Expert Review of Anti-infective Therapy·Alian A AlrasheedyMohammed S Anaam
Apr 24, 2014·Research and Reports in Tropical Medicine·Beverley D Glass

❮ Previous
Next ❯

Citations

Sep 18, 2020·Journal of Pharmaceutical Policy and Practice·Gamal Khalafalla Mohamed AliAbubakr Abdelraouf Alfadl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.